Ingulados Research

INTENSIVE RESEARCH

R&D&i

It arises as an entity linked to INGULADOS with the aim of intensifying research and developing new products with added value in the field of health. This new entity is owned by INGULADOS (Spain) and Salbo Scientific LTD (United Kingdom) (https://salbo.co.uk).
INGULADOS RESEARCH collaborates with different public and private entities in research projects in the field of biosciences and health.

Facing

considerable challenges

Contributing

to knowledge

Research Projects

Talent management

Any great project is drawn by its talented people thereof

Pedro Fernández Llario

Ingulados CEO

Pedro Fernández Llario, currently INGULADOS CEO, has extensive professional experience in the field of animal health and production. Since the foundation of Ingulados, he has worked on equipping the company with the different professional profiles and infrastructures facing new challenges in the field of health (One Health). That is not to forget that the development lies in its own research and due to the synergy with other research groups, both public and private, nationally and internationally.

Javier Salguero

Salbo Scientific CEO

Javier Salguero is an expert consultant in Pathology and Infectious Diseases. He is Doctor in Veterinary Medicine and PhD and has an extensive experience as a researcher in the pathogenesis and diagnosis of transboundary and emerging diseases that affect both humans and animals. He is currently a member of the Pathology Department of Public Health England (PHE Porton, UK) and CEO of Salbo Scientific LTD where he carries out numerous consulting missions for international organizations, such as FAO and the EU, and has an extensive national and international network of collaborators.